VSee Health (VSEE) Competitors $1.22 +0.04 (+3.39%) Closing price 03:47 PM EasternExtended Trading$1.20 -0.02 (-2.05%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VSEE vs. ENZ, BRTX, MGRX, SSY, ACON, ATIP, DHAC, OTRK, NIVF, and BACKShould you be buying VSee Health stock or one of its competitors? The main competitors of VSee Health include Enzo Biochem (ENZ), Biorestorative Therapies (BRTX), Mangoceuticals (MGRX), SunLink Health Systems (SSY), Aclarion (ACON), ATI Physical Therapy (ATIP), Digital Health Acquisition (DHAC), Ontrak (OTRK), NewGenIvf Group (NIVF), and IMAC (BACK). These companies are all part of the "healthcare" industry. VSee Health vs. Its Competitors Enzo Biochem Biorestorative Therapies Mangoceuticals SunLink Health Systems Aclarion ATI Physical Therapy Digital Health Acquisition Ontrak NewGenIvf Group IMAC VSee Health (NASDAQ:VSEE) and Enzo Biochem (NYSE:ENZ) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk. Do analysts prefer VSEE or ENZ? VSee Health currently has a consensus target price of $5.00, suggesting a potential upside of 309.84%. Given VSee Health's stronger consensus rating and higher possible upside, analysts clearly believe VSee Health is more favorable than Enzo Biochem.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VSee Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00Enzo Biochem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders have more ownership in VSEE or ENZ? 1.0% of VSee Health shares are owned by institutional investors. Comparatively, 36.9% of Enzo Biochem shares are owned by institutional investors. 6.6% of VSee Health shares are owned by insiders. Comparatively, 11.4% of Enzo Biochem shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media favor VSEE or ENZ? In the previous week, VSee Health had 1 more articles in the media than Enzo Biochem. MarketBeat recorded 1 mentions for VSee Health and 0 mentions for Enzo Biochem. VSee Health's average media sentiment score of 1.87 beat Enzo Biochem's score of 0.00 indicating that VSee Health is being referred to more favorably in the media. Company Overall Sentiment VSee Health Very Positive Enzo Biochem Neutral Is VSEE or ENZ more profitable? VSee Health has a net margin of 0.00% compared to Enzo Biochem's net margin of -75.34%. VSee Health's return on equity of 0.00% beat Enzo Biochem's return on equity.Company Net Margins Return on Equity Return on Assets VSee HealthN/A N/A N/A Enzo Biochem -75.34%-7.96%-5.49% Which has preferable earnings and valuation, VSEE or ENZ? VSee Health has higher earnings, but lower revenue than Enzo Biochem. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVSee HealthN/AN/A-$4.41MN/AN/AEnzo Biochem$29.09M0.59-$26.08MN/AN/A SummaryVSee Health beats Enzo Biochem on 9 of the 12 factors compared between the two stocks. Get VSee Health News Delivered to You Automatically Sign up to receive the latest news and ratings for VSEE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VSEE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VSEE vs. The Competition Export to ExcelMetricVSee HealthINTERNET SOFTWARE IndustryComputer SectorNASDAQ ExchangeMarket CapN/A$18.13B$27.76B$9.11BDividend YieldN/A2.44%3.11%4.01%P/E RatioN/A71.7436.8520.25Price / SalesN/A70.291,883.2599.65Price / CashN/A93.0238.1558.16Price / Book-0.368.437.275.49Net Income-$4.41M$337.83M$767.31M$250.27M7 Day Performance4.27%-1.29%-0.14%4.78%1 Month Performance7.02%1.78%4.24%7.20%1 Year Performance-81.49%53.17%52,442.29%17.27% VSee Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VSEEVSee Health1.2662 of 5 stars$1.22+3.4%$5.00+309.8%N/A$0.00N/A0.00N/APositive NewsENZEnzo BiochemN/A$0.33-14.8%N/A-69.9%$17.03M$29.09M0.00520Gap DownHigh Trading VolumeBRTXBiorestorative Therapies3.6601 of 5 stars$1.66-0.6%$18.00+987.6%-10.6%$12.42M$391K-1.137Gap UpMGRXMangoceuticals0.7706 of 5 stars$1.50-1.3%N/A-97.7%$7.76M$620K-0.323Positive NewsSSYSunLink Health Systems2.3392 of 5 stars$0.93+5.2%N/A+31.7%$6.52M$31.09M6.611,376ACONAclarion2.8169 of 5 stars$7.52-0.1%$11,758.50+156,263.0%-99.7%$4.36M$50K0.007ATIPATI Physical TherapyN/A$0.90+4.7%N/A-82.5%$3.97M$741.86M-0.055,600Upcoming EarningsDHACDigital Health AcquisitionN/A$1.10-3.5%N/A-81.6%$3.96MN/A0.002,021News CoverageGap DownOTRKOntrak2.6716 of 5 stars$0.44-11.0%$45.00+10,035.1%-86.3%$1.88M$10.85M-0.03250News CoverageAnalyst ForecastAnalyst RevisionNIVFNewGenIvf GroupN/A$1.02-2.4%N/A-99.7%$538K$5.43M0.00N/APositive NewsGap UpHigh Trading VolumeBACKIMACN/A$0.06+24.0%N/A-94.9%$128K$72.05K0.00180 Related Companies and Tools Related Companies Enzo Biochem Competitors Biorestorative Therapies Competitors Mangoceuticals Competitors SunLink Health Systems Competitors Aclarion Competitors ATI Physical Therapy Competitors Digital Health Acquisition Competitors Ontrak Competitors NewGenIvf Group Competitors IMAC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VSEE) was last updated on 7/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VSee Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share VSee Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VSEE Stock Alerts